…G) has gained traction as a minimally invasive intervention for obesity, delivering notable weight loss and metabolic benefits. However…
metabolic dysfunction-associated steatotic liver disease
This disease is selected. Its supporting articles are shown below.
Articles mentioning metabolic dysfunction-associated steatotic liver disease
40 articles · page 2 of 4…Background Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide.…
…Introduction Steatotic liver disease (SLD), particularly its metabolic forms (metabolic dysfunction-associ…
…s, metabolic dysfunction-associated steatotic liver disease and atherosclerotic cardiovascular disease, are increasingly prevalent among individuals with inflammatory…
…Steatotic liver disease (SLD) is an umbrella term mainly encompassing metabolic dysfunc…
… issues regarding the implementation of non-invasive test-based hepatocellular carcinoma (HCC) surveillance in patients with metabolic dysfunction-assoc…
…SM) ≥20 kPa (or LSM ≥15 kPa in the two-step algorithm)—to guide hepatocellular carcinoma (HCC) surveillance in patients with metabolic dysfunction-assoc…
…Liver fibrosis represents a serious worldwide health issue with a prevalence o…
…are, seems paramount, especially in the high-risk patients with type 2 diabetes and/or obesity. As we discuss in this review, the diagnosis and…
…Globally, liver disease accounts for more than 2 million deaths and is the 11th leading…
…hronic hepatitis B (CHB) remains a major cause of cirrhosis and hepatocellular carcinoma (HCC) worldwide, affecting over 250 million people. In the UK, …
Clarifying the decision rules and implementation boundaries for risk-based HCC surveillance in MASLD
…olic dysfunction-associated steatotic liver disease (MASLD) for hepatocellular carcinoma (HCC) surveillance via fibrosis-4 index (FIB-4) and vibration-c…